Insider Transactions in Q3 2021 at Royalty Pharma PLC (RPRX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
992
+4.17%
|
$36,704
$37.8 P/Share
|
|
Sep 30
2021
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
992
+5.52%
|
$36,704
$37.8 P/Share
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
936,427
-14.1%
|
-
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
63,777
-1.56%
|
$2,295,972
$36.43 P/Share
|
|
Sep 29
2021
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
16,274
+0.86%
|
-
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
24,648
-3.85%
|
$887,328
$36.5 P/Share
|
|
Sep 28
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
40,000
-5.88%
|
$1,440,000
$36.75 P/Share
|
|
Jul 26
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
17,898
-0.76%
|
$698,022
$39.78 P/Share
|
|
Jul 26
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
13,362
-0.94%
|
$521,118
$39.79 P/Share
|
|
Jul 14
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2
-0.0%
|
$84
$42.0 P/Share
|
|
Jul 13
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
17,832
-1.49%
|
$748,944
$42.01 P/Share
|
|
Jul 13
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
23,049
-1.53%
|
$968,058
$42.01 P/Share
|
|
Jul 12
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
100
-0.01%
|
$4,200
$42.04 P/Share
|
|
Jul 12
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
100
-0.01%
|
$4,200
$42.04 P/Share
|
|
Jul 08
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
49,059
-3.08%
|
$2,060,478
$42.05 P/Share
|
|
Jul 08
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
40,655
-3.28%
|
$1,707,510
$42.05 P/Share
|
|
Jul 07
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
2,900
-0.18%
|
$121,800
$42.01 P/Share
|
|
Jul 07
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,192
-0.18%
|
$92,064
$42.01 P/Share
|
|
Jul 06
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
36,530
-2.22%
|
$1,534,260
$42.41 P/Share
|
|
Jul 06
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
30,270
-2.38%
|
$1,271,340
$42.4 P/Share
|